A smarter way to manage asthma with a combination of a long-acting β₂-agonist and inhaled corticosteroid

References

• AalbersRBackerVKavaKKAdjustable maintenance dosing with budesonide-formoterol compared with fixed-dose salmeterol-fluticasone in moderate to severe asthmaCurr Med Res Opin2004202254015006018
   PubMed Web of Science ®Google Scholar
• AngusRReagonRCheesbroughAShort-acting β2-agonist and oral corticosteroid use in asthma patients prescribed either concurrent beclomethasone and long-acting β2-agonist or salmeterol-fluticasone propionate combinationInt J Clin Pract2005591566215854190
   PubMedGoogle Scholar
• AnkerstJPerssonGWeibullETolerability of a high dose of budesonide-formoterol in a single inhaler in patients with asthmaPulm Pharmacol Ther2003161475112749830
   PubMed Web of Science ®Google Scholar
• BarnesPJScientific rationale for inhaled combination therapy with long-acting β2-agonists and corticosteroidsEur Respir J2002191829111843317
   PubMed Web of Science ®Google Scholar
• BarnesPJScientific rationale for using a single inhaler for asthma controlEur Respir J2007295879517329493
   PubMed Web of Science ®Google Scholar
• BennettJATattersfieldAETime course and relative dose potency of systemic effects from salmeterol and salbutamol in healthy subjectsThorax199752458649176539
   PubMed Web of Science ®Google Scholar
• BisgaardHLeRouxPBjåmerDBudesonide-formoterol maintenance plus reliever therapy: a new strategy in pediatric asthmaChest200613017334317166990
   PubMed Web of Science ®Google Scholar
• BoonsawatWCharoenratanakulSPothiratanaCFormoterol (Oxis®) Turbuhaler® as a rescue therapy compared with salbutamol by pMDI plus spacer in patients with acute severe asthmaRespir Med20039710677414509562
   PubMed Web of Science ®Google Scholar
• BousheyHASorknessCAKingTSDaily versus as needed corticosteroids for mild persistent asthmaN Engl J Med200535251928
   Google Scholar
• BuhlRKardosPRichterKThe effect of adjustable dosing with budesonide-formoterol on health-related quality of life and asthma control compared with fixed dosingCurr Med Res Opin20042012092915324523
   PubMed Web of Science ®Google Scholar
• BusseWWChervinskyPCondemiJBudesonide delivered by Turbuhaler is effective in a dose-dependent fashion when used in the treatment of adult patients with chronic asthmaJ Allergy Clin Immunol1998101457639564797
   PubMed Web of Science ®Google Scholar
• CanonicaGWCastellaniPCazzolaMAdjustable maintenance dosing with budesonide-formoterol in a single inhaler provides effective asthma symptom control at a lower dose than fixed maintenance dosingPulm Pharmacol Ther2004172394715219269
   PubMed Web of Science ®Google Scholar
• Ellul-MicallefRJohanssonS-AAcute dose-response studies in bronchial asthma with a new corticosteroid, budesonideBr J Clin Pharmacol1983115419226342643
   PubMedGoogle Scholar
• FitzGeraldJMSearsMRBouletL-PAdjustable maintenance dosing with budesonide-formoterol reduces asthma exacerbations compared with traditional fixed dosing: a five-month multicentre Canadian studyCan Respir J2003104273414679407
   PubMedGoogle Scholar
• FitzGeraldJMBeckerASearsMRDoubling the dose of budesonide versus maintenance treatment in asthma exacerbationsThorax200459550615223858
   PubMed Web of Science ®Google Scholar
• FitzGeraldJMBouletL-PFollowsRMAThe CONCEPT trial: a 1-year, multicenter, randomized, double-blind, double-dummy comparison of a stable dosing regimen of salmeterol-fluticasone propionate with an adjustable maintenance dosing regimen of formoterol/budesonide in adults with persistent asthmaClin Ther20052739340615922813
   PubMed Web of Science ®Google Scholar
• ForesiAMorelliMCCatenaELow-dose budesonide with the addition of an increased dose during exacerbations is effective in long-term asthma controlChest2000117440610669688
   PubMed Web of Science ®Google Scholar
• GarrettJWilliamsSWongCTreatment of acute exacerbations with an increased dose of inhaled steroidArch Dis Child19987912179771245
   PubMed Web of Science ®Google Scholar
• GibsonPGSaltosNFakesKAcute anti-inflammatory effects of inhaled budesonide in asthma: a randomized controlled trialAm J Respir Crit Care Med200116332611208622
   PubMed Web of Science ®Google Scholar
• GibsonPGTeaching old drugs new tricks: asthma therapy adjusted by patient perception or noninvasive markersEur Respir J200525397915738278
   PubMed Web of Science ®Google Scholar
• GuhanARCooperSOborneJSystemic effects of formoterol and salmeterol : a dose-response comparison in healthy subjectsThorax200055650610899240
   PubMed Web of Science ®Google Scholar
• HaahtelaTJärvinenMKavaTEffects of reducing or discontinuing inhaled budesonide in patients with mild asthmaN Engl J Med199433170058058076
   PubMed Web of Science ®Google Scholar
• HaahtelaTTuomistoLEPietinalhoAA 10 year asthma programme in Finland: major change for the betterThorax2006616637016877690
   PubMed Web of Science ®Google Scholar
• HaqueRAJohnsonMAdcockIMAddition of salmeterol to fluticasone prolongs retention of glucocorticoid receptors within the nucleus of BEAS-2B cells and enhances downstream glucocorticoid effectsProc Am Thorac Soc20063A78
   Google Scholar
• HarrisonTWOborneJNewtonSDoubling the dose of inhaled corticosteroid to prevent asthma exacerbations: randomised controlled trialLancet2004363271514751699
   PubMed Web of Science ®Google Scholar
• HaughneyJBarnesGPartridgeMThe living and breathing study: a study of patients’ views of asthma and its treatmentsPrim Care Resp J2004132835
   PubMedGoogle Scholar
• HaughneyJFletcherMWolfeSFeatures of asthma management: quantifying the patient’s perspective using discrete choice modellingEur Respir J200628suppl 50122s
   Google Scholar
• HoltSRyder-LewisSMasoliMFixed and adjustable dose asthma action plans based on combination therapy: a pilot studyRespirology20051049750316135174
   PubMedGoogle Scholar
• HylandMEStåhlEAsthma treatment needs: a comparison of patients’ and health care professionals’ perceptionsClin Ther20042621415215823778
   PubMed Web of Science ®Google Scholar
• IndPWHaughneyJPriceDAdjustable and fixed dosing with budesonide-formoterol via a single inhaler in asthma patients: the ASSURE studyRespir Med2004984647515139576
   PubMed Web of Science ®Google Scholar
• JatakanonALimSBarnesPJChanges in sputum eosinophils predict loss of asthma controlAm J Respir Crit Care Med2000161647210619799
   PubMed Web of Science ®Google Scholar
• JuniperEFO’ByrnePMGuyattGHDevelopment and validation of questionnaire to measure asthma controlEur Respir J199914902710573240
   PubMed Web of Science ®Google Scholar
• JuniperEFSvenssonKMörkA-CMeasurement properties and interpretation of three shortened versions of the asthma control questionnaireRespir Med200599553815823451
   PubMed Web of Science ®Google Scholar
• KunaPPetersJBuhlRBudesonide-formoterol as maintenance and reliever therapy reduces asthma exacerbations versus a higher maintenance dose of budesonide-formoterol or salmeterol-fluticasoneEur Respir J200628suppl 50205s
   Google Scholar
• LeuppiJDSalzbergMMeyerLAn individualized, adjustable maintenance regimen of budesonide-formoterol provides effective asthma symptom control at a lower overall dose than fixed dosingSwiss Med Wkly2003133302912861468
   PubMed Web of Science ®Google Scholar
• LundborgMWilleSBjermerLMaintenance plus reliever budesonide-formoterol compared with a higher maintenance dose of budesonide-formoterol plus formoterol as reliever in asthma: an efficacy and cost-effectiveness studyCurr Med Res Opin2005228092116709303
   PubMedGoogle Scholar
• MalolepszyJBöszörményi NagyGSelroosOSafety of formoterol Turbuhaler at cumulative doses of 90 g in patients with acute bronchial obstructionEur Respir J2001189283411829098
   PubMed Web of Science ®Google Scholar
• ManeechotesuwanKUsmaniOSAdcockIMThe modulation of GATA-3 nuclear localization by fluticasone & salmeterolAm J Respir Crit Care Med2002165A616
   Google Scholar
• ManeechotesuwanKEssilfie-QuayeSMeahSFormoterol attenuates neutrophilic airway inflammation in asthmaChest200512819364216236838
   PubMed Web of Science ®Google Scholar
• Miller-LarssonASelroosOAdvances in asthma and COPD treatment: combination therapy with inhaled corticosteroids and long-acting β2-agonistsCurr Pharmaceut Design200612326179
   PubMedGoogle Scholar
• [NIH GINA] National Institutes of Health, Global Initiative for AsthmaGlobal strategy for asthma management and prevention [online]2006 Accessed December 2006. URL: http://www.ginasthma.org/. NIH Publication No 02–3659, Bethesda, MD, 1995 (updated 2006)
   Google Scholar
• O’ByrnePMBarnesPJRodriguez-RousinRLow dose inhaled budesonide and formoterol in mild persistent asthma. The OPTIMA randomized trailAm J Respir Crit Care Med20011641392711704584
   PubMed Web of Science ®Google Scholar
• O’ByrnePMDaily inhaled corticosteroid treatment should be prescribed for mild persistent asthmaAm J Respir Crit Care Med20051724101216081553
   PubMedGoogle Scholar
• O’ByrnePMBisgaardHGodardPPBudesonide-formoterol combination therapy as both maintenance and reliever medication in asthmaAm J Respir Crit Care Med20051711293615502112
   PubMed Web of Science ®Google Scholar
• PalmqvistMPerssonGLazerLInhaled dry-powder formoterol and salmeterol in asthmatic patients; onset of action, duration of effect and potencyEur Respir J199710248499426083
   PubMed Web of Science ®Google Scholar
• PalmqvistMIbsenTMellenAComparison of the relative efficacy of formoterol and salmeterol in asthmatic patientsAm J Respir Crit Care Med1999160244910390407
   PubMed Web of Science ®Google Scholar
• PalmqvistMArvidssonPBeckmanOOnset of bronchodilation of budesonide-formoterol vs. salmeterol-fluticasone in single inhalersPulm Pharmacol Ther200114293411162416
   PubMed Web of Science ®Google Scholar
• PartridgeMvan der MolenTMyrsethS-EAttitudes and actions of asthma patients on regular maintenance therapy: The INSPIRE studyBMC Pulm Med200661316772035
   PubMedGoogle Scholar
• PauwelsRALöfdahlC-GPostmaDSEffect of inhaled formoterol and budesonide on exacerbations of asthmaN Engl J Med19973371405119358137
   PubMed Web of Science ®Google Scholar
• PolitiekMJBoorsmaMAalbersRComparison of formoterol, salbutamol and salmeterol in methacholine-induced severe bronchoconstrictionEur Respir J1999139889210414394
   PubMed Web of Science ®Google Scholar
• RabeKFVermeirePASorianoJBClinical management of asthma in 1999: the Asthma Insight and Reality in Europe (AIRE) studyEur Respir J200016802711153575
   PubMed Web of Science ®Google Scholar
• RabeKFAdachiMLaiCKWWorldwide severity and control of asthma in children and adults: the global Asthma Insight and Reality surveysJ Allergy Clin Immunol200411440715241342
   PubMed Web of Science ®Google Scholar
• RabeKFPizzichiniEStällbergBBudesonide-formoterol in a single inhaler for maintenance and relief in mild-to-moderate asthma. A randomized, double-blind trialChest20061292465616478838
   PubMed Web of Science ®Google Scholar
• RabeKFAtienzaTMagyarPEffect of budesonide in combination with formoterol for reliever therapy in asthma exacerbations: a randomised controlled, double-blind studyLancet20063687445316935685
   PubMed Web of Science ®Google Scholar
• RingdalNDeromEWåhlin-BollEOnset and duration of action of single doses of formoterol inhaled via TurbuhalerRespir Med1998921017219893769
   PubMed Web of Science ®Google Scholar
• RosenborgJBengtssonTLarssonPRelative systemic dose potency and tolerability of inhaled formoterol and salbutamol in healthy subjects and asthmaticsEur J Clin Pharmacol2000563637011009043
   PubMed Web of Science ®Google Scholar
• RosenborgJLarssonPRottZRelative therapeutic index between inhaled formoterol and salbutamol in asthma patientsRespir Med2002964121712117040
   PubMedGoogle Scholar
• RosenhallLHeinigJHLindqvistABudesonide-formoterol (Symbicort®) is well tolerated and effective in patients with moderate persistent asthmaInt J Clin Pract2002564273312166540
   PubMed Web of Science ®Google Scholar
• RosenhallLElvstrandATillingBOne-year safety and efficacy of budesonide-formoterol in a single inhaler (Symbicort® Turbuhaler®) for the treatment of asthmaRespir Med200397702812814158
   PubMed Web of Science ®Google Scholar
• RubinfeldARScicchitanoRHuntAFormoterol Turbuhaler® as reliever medication in patients with acute asthmaEur Respir J2006277354116455838
   PubMed Web of Science ®Google Scholar
• ScicchitanoRAalbersRUkenaDEfficacy and safety of budesonide-formoterol single inhaler therapy versus a higher dose of budesonide in moderate to severe asthmaCurr Med Res Opin20042014031815383189
   PubMed Web of Science ®Google Scholar
• SeberováEAnderssonAOxis (formoterol given by Turbuhaler) showed as rapid an onset of action as salbutamol given by pMDIRespir Med2000946071110921767
   PubMed Web of Science ®Google Scholar
• StällbergBOlssonPJörgensenLABudesonide-formoterol adjustable maintenance dosing reduces asthma exacerbations versus fixed dosingInt J Clin Pract2003576566114627173
   PubMed Web of Science ®Google Scholar
• TöttermanKJHuhtiLSutinenETolerability of high doses of formoterol and terbutaline via Turbuhaler® for 3 days in stable asthmatic patientsEur Respir J19981257399762782
   PubMed Web of Science ®Google Scholar
• TsaiYGLeeMYYangKDA single dose of nebulized budesonide decreases exhaled nitric oxide in children with acute asthmaJ Pediatr2001139433711562625
   PubMed Web of Science ®Google Scholar
• UllmanASvedmyrNSalmeterol, a new long acting inhaled beta2adrenoceptor agonist: comparison with salbutamol in adult asthmatic patientsThorax19884367482904183
   PubMed Web of Science ®Google Scholar
• UsmaniOSItoKManeechotesuwanKGlucocorticoid receptor nuclear translocation in airway cells after inhaled combination therapyAm J Respir Crit Care Med20051727041215860753
   PubMed Web of Science ®Google Scholar
• van der WoudeHJBoorsmaMBergqvistPBFBudesonideformoterol in a single inhaler rapidly relieves methacholine-induced moderate-to-severe bronchoconstrictionPulm Pharmacol Ther200417899515123230
   PubMed Web of Science ®Google Scholar
• VogelmeierCD’UrzoAPauwelsRBudesonide-formoterol maintenance and reliever therapy: an effective asthma treatment option?Eur Respir J2005268192816264042
   PubMed Web of Science ®Google Scholar
• ZetterströmOBuhlRMellemHImproved asthma control with budesonide-formoterol in a single inhaler, compared with budesonide aloneEur Respir J200118262811529282
   PubMed Web of Science ®Google Scholar